Program for DAY 2, February 28 (Thursday) 第 2 日 2 月 28 日 ( 木 ) プログラム

Transkript

1 Program for DAY 2, (Thursday) 第 2 日 2 月 28 日 ( 木 ) プログラム (Thursday) Room 1 2 月 28 日 ( 木 ) 第 1 会場 8:30~10:00 英語 in English / 日本語 in Japanese Sponsored Symposium 1 スポンサードシンポジウム1 Room 1 Exhibition Hall 1 第 1 会場多目的ホール 1 Checkpoint Inhibitors for MSI-High Gastric Cancer 胃癌領域におけるがん免疫療法とマイクロサテライト不安定性 (MSI) 座長 : 小寺泰弘 ( 名古屋大学大学院医学系研究科消化器外科学 ) Yasuhiro Kodera( Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine) 室圭 ( 愛知県がんセンター中央病院薬物療法部 ) Kei Muro(Department of Clinical Oncology, Aichi Cancer Center Hospital) 演者 : 中島貴子 ( 聖マリアンナ医科大学臨床腫瘍学講座 ) Takako Nakajima( Department of Clinical Oncology, St. Marianna University School of Medicine) 沖英次 ( 九州大学大学院消化器 総合外科 ) Eiji Oki( Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University) Zev A. Wainberg( GI Oncology Program, Department of Medicine, University of California, Los Angeles) 共催 :MSD 株式会社 / 大鵬薬品工業株式会社 Sponsored by:msd KK. / TAIHO PHARMACEUTICAL CO., LTD. 10:05~11:35 英語 in English Room 1 Exhibition Hall 1 Panel Discussion 1 Role of splenic hilar lymph node dissection in proximal gastric cancer Chairs Takeshi Sano( Japanese Foudation for Cancer Research Cancer Institute Hospital, Hospital Director) Takahiro Kinoshita( Gastric Surgery Division National Cancer Center Hospital East) PD1-1 PD1-2 PD1-3 PD1-4 PD1-5 PD1-6 Research Progress of Laparoscopic Spleen-Preserving No.10 Lymph Node Dissection for Gastric Cancer in Our Center Changming Huang(Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China) The strategy of totally laparoscopic reconstruction for Esophagogastric Junction Cancer Zekuan Xu(The First Affiliated Hospital of Nanjing Medical University, Nanjing, China) Splenic hilar nodal dissection for advanced proximal gastric cancer invading the greater curvature Masahiro Yura(Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Role of splenectomy for upper and/or middle gastric cancer involving the greater curvature Yosuke Kano(Department of Gastroenterological Surgery, Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Significance of splenectomy for upper third gastric cancer in the greater curvature Takashi Nomura(Surgery, Yamagata Prefectural Central Hospital, Yamagata, Risk factors for splenic hilar node metastasis in adenocarcinoma of the esophagogastric junction Yuta Kumazu(Dept.of GI Surgery, Kanagawa Cancer Center) Special Remarks Hiroshi Isozaki(Oomoto Hospital) 64

2 13:00~14:00 日本語 in Japanese Special Lecture 2 The Cancer Genome Atlas for Japanese Cancer Patients 特別講演 2 がんゲノム医療の実践 多職種チーム医療での取り組み Chair Hitoshi Katai( Department of Gastric Surgery National Cancer Center Hospital) 座長 片井均 ( 独立行政法人国立がん研究センター中央病院胃外科 ) SL2 The Cancer Genome Atlas for Japanese Cancer Patients がんゲノム医療の実践 多職種チーム医療での取り組み Ken Yamaguchi(Shizuoka Cancer Center) 山口建 ( 静岡県立静岡がんセンター ) Room 1 Exhibition Hall 1 第 1 会場多目的ホール 1 Room1 14:05~16:05 英語 in English Room 1 Exhibition Hall 1 Symposium 5 New evidence for perioperative chemotherapy Chairs Takaki Yoshikawa( Department of Gastric Surgery, National Cancer Center Hospital) Hideo Baba( Department of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University) SY5-1 SY5-2 SY5-3 SY5-4 SY5-5 SY5-6 Perspectives of postoperative chemotherapy for gastric cancer: From Asian point of view Takako Nakajima(Department of Clinical Oncology, St.Marianna University School of Medicine, Kawasaki, Development of multi-disciplinary treatment for gastric cancer with extensive lymph node metastasis Seiji Ito(Aichi Cancer Center Hospital, Aichi, JCOG trials to investigate the efficacy of neoadjuvant chemotherapy for locally advanced gastric cancer Masanori Tokunaga(Gastric Surgery Division, National Cancer Center Hospital East) Immunotherapy with checkpoint inhibitors (CPI)shows solid activity in advanced gastric cancers Markus Moehler(Mainz University Clinic, I. Dept. Medicine, of Internal GI Oncology, Germany) Peri-operative FLOT-therapy and perspectives for curation of locally advanced, resectable gastric cancer Salah-Eddin Al-Batran(Institute of Clinical Cancer Research, Krankenhaus Nordwest, UCT University Cancer Center, Frankfurt am Main, Germany) Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? Maurizio Degiuli(San Luigi University Hospital, Surgical Oncology and Digestive Surgery, University of Turin, Turin, Italy) Special Remarks Junichi Sakamoto(Tokai Central Hospital) 65

3 (Thursday) Room 2 2 月 28 日 ( 木 ) 第 2 会場 8:30~10:00 英語 in English Room 2 Exhibition Hall 3 Symposium 1 EGJ tumor update: Topics from epidemiology and diagnosis Chairs Yasuyuki Seto( Department of Gastrointestinal Surgery, The University of Tokyo Hospital) Ichiro Oda( Endoscopy Division, National Cancer Center Hospital) SY1-1 SY1-2 SY1-3 SY1-4 SY1-5 SY1-6 Epidemiology of esophagogastric junction (EGJ)cancer Manami Inoue(Division of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, The time trend in superficial esophagogastric junction adenocarcinoma Kenshi Matsuno(Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Two distinct etiologies of esophagogastric junction cancer: Related with H.pylori and reflux Ken-ichi Mukaisho(Division of Molecular Diagnostic Pathology, Department of Pathology, Shiga University of Medical Science) Endoscopic treatment for Esophago gastric Junctional adenocarcinoma Tsuneo Oyama(Department of Endoscopy, Saku Central Hospital Advanced Care Center) Endoscopic findings of adenocarcinoma in esophagogastric junction Hiroyoshi Iwagami(Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Endoscopic prediction of deep submucosal invasion of adenocarcinomas on esophagogastric junction Shigetaka Yoshinaga(Endoscopy Division, National Cancer Center Hospital, Tokyo, Special Remarks Takashi Aikou(Kagoshima University Graduate School of Medical and Dental Sciences) 10:05~11:35 英語 in English Room 2 Exhibition Hall 3 Symposium 2 EGJ tumor up-to-date: Topics from current treatment Chairs Yuko Kitagawa( Department of Surgery, Keio University School of Medicine) Yuichiro Doki( Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University) SY2-1 SY2-2 SY2-3 SY2-4 SY2-5 Adjuvant, neoadjuvant or perioperative therapy? Magnus Nilsson(Karolinska Institutet, Stockholm, Sweden) Lymphadenectomy of mediastinum and GIRAFFE reconstruction for EGJ Xiang dong Cheng(The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China) EGJ Tumors: Controversies in Treatment Simon Law(Department of Surgery, The University of Hong Kong) Global, Asian and Indian Prespective S.M. Chandramohan(India) Intrathoracic double-flap technique after laparoscopic proximal gastrectomy for junctional cancer Hirofumi Kawakubo(Department of Surgery, Keio University School of Medicine) 66

4 SY2-6 Optimal lymph node dissection for esophagogastric junction cancer: a multicenter prospective study Yukinori Kurokawa(Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Special Remarks Atsushi Nashimoto(Nanbugo General Hospital) (Thursday) Room 3 2 月 28 日 ( 木 ) 第 3 会場 8:30~10:00 英語 in English Room 3 Convention Hall A-1 Video Workshop 1 Current status and perspectives of para-aortic lymph node dissection Chairs Hitoshi Katai( Department of Gastric Surgery National Cancer Center Hospital) Shoji Natsugoe( Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University Graduate School of Medical and Dental Sciences) Room2~3 VWS1-1 Clinical significance of paraaortic lymph node dissection following preoperative chemotherapy Hitoshi Katai(Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, VWS1-2 Long-term outcome of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 followed by para-aortic lymph node dissection for gastric cancer with extensive nodal metastasis (JCOG1002) Yoshiyuki Kawashima(Department of Gatroenterological Surgery, Saitama Cancer Center, Saitama, VWS1-3 VWS1-4 VWS1-5 The role of ara-aortic lymph node dissection Franco Roviello(University of Siena) Current status and perspective of para-aortic lymph node dissection following modified DCS therapy Sachio Fushida(Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, Surgical technique and outcomes of gastrectomy following NAC for gastric cancer with PALN metastasis Manabu Ohashi(Division of Gastri Surgery, Gastroenterological Center, Cancer Institute Hospital, Tokyo, Special Remarks Hiroshi Furukawa(Kishiwada Tokushukai Hospital / Department of Surgery, Kindai University Hospital) 10:05~11:35 英語 in English Room 3 Convention Hall A-1 Workshop 3 Navigation surgery for gastric cancer Chairs Hiroya Takeuchi( Department of Surgery, Hamamatsu University School of Medicine) Norio Mitsumori( Division of Upper Gastrointestinal Surgery, The Jikei University Hospital) WS3-1 WS3-2 A fluorescence image-guided technique for identification of left aberrant hepatic artery territory Taeil Son(Yonsei University College of Medicine) Looking for safety and curability of laparoscopic gastrectomy by ICG fluorescence navigation method Yoshimasa Aoyama(Osaka International Cancer Institute, Osaka, 67

5 WS3-3 WS3-4 WS3-5 WS3-6 WS3-7 Feasibility study for SN mapping by ICG and OSNA in laparoscopic gastric cancer surgery Yoshiaki Shoji(Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research) Preoperative simulation using 3D-fusion image for laparoscopic gastrectomy Yoshihiro Hiramatsu(Department of Surgery, Hamamatsu Univesity School of Medicine / Department of Perioperative Functioning Care & Support, Hamamatsu Univesity School of Medicine) Clinical outcomes of ICG plus infrared ray observation for SNNS against early gastric cancer Naoto Takahashi(Department of Surgery, The Jikei University Kashiwa Hospital, Chiba, Indocyanine green fluorescence lymphatic navigation and sentinel node biopsy in gastric surgery Shinichi Kinami(Department of Surgical Oncology, Kanazawa Medical University) Sentinel Node Navigation Surgery for Gastric Cancer Hirofumi Kawakubo(Department of Surgery, Keio University School of Medicine) Special Remarks Akira Kurita(Nasional Hospital Organization Shikoku Cancer Center) 14:05~15:35 英語 in English Room 3 Convention Hall A-1 Symposium 6 The role of conversion surgery Chairs Kazuhiro Yoshida( Department of Surgical Oncology, Gifu University School of Medicine) Yoshiyuki Fujiwara( Department of Surgery, Faculty of Medicine, Tottori University) SY6-1 SY6-2 SY6-3 SY6-4 SY6-5 SY6-6 SY6-7 SY6-8 Conversion therapy for advanced gastric cancer in the First Hospital of Jilin University Jian Suo(The First Hospital of Jilin University, Changchun, China) Aggressive R0 surgical resection in chemo-responsive patients may prolong survival in stage IV gastric cancer Cho Hyun Park(Seoul St. Mary s Hospital, The Catholic University of Korea, Seoul, Republic of Korea) Retrospective study of conversion therapy using two drugs chemotherapy with Apatinib in unresectable stage IV gastric cancer Han Liang(Tianjin Medical University Cancer Institute & Hospital, Tianjin, China) An analysis of conversion therapy for advanced gastric cancer in Gifu university hospital Itaru Yasufuku(Department of Surgical Oncology, Gifu University Graduate School of Medicine) The effect of multimodal therapy with DCS therapy plus resection for stage 4 gastric cancer Jun Kinoshita(Department of Gastroenterologic Surgery, Kanazawa University, Kanazawa, Surgery in stage IV gastric cancer Italian perspective Alessia D'Ignazio(University of Siena, Italy) Conversion surgery for gastric cancer with peritoneal metastasis or positive peritoneal cytology Ryo Takahashi(Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Multidisciplinary treatment for gastric cancer with peritoneal metastasis or positive cytology Hironori Ishigami(Department of Chemotherapy, The University of Tokyo, Tokyo, Special Remarks Hisakazu Yamagishi(Kyoto Medical Support Center) 68

6 (Thursday) Room 4 2 月 28 日 ( 木 ) 第 4 会場 8:30~10:00 英語 in English Room 4 Convention Hall A-2 Workshop 1 Chemotherapy with limited indication Chairs Kensei Yamaguchi( Department Director of Gastroenterological Chemotherapy Center Chief. Clinical Research & Medical development Center Department Director of Clinical Trial Planning and Management. Vice Director of Clinical Trial Support Department. Cancer Institute Hospit) Nozomu Machida( Division of Gastrointestinal Oncology, Shizuoka Cancer Center) WS1-1 WS1-2 WS1-3 WS1-4 WS1-5 WS1-6 The role and possibility of FOLFOX for advanced gastric cancer Toshiki Masuishi(Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Modified FOLFOX6 for advanced gastric cancer patients with massive ascites or inadequate oral intake Hiroki Osumi(Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research) Nab-PTX plus ramucirumab in patients with pre-treated advanced/recurrent gastric cancer Atsuo Takashima(Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital) Safety and efficacy of nab-ptx + RAM therapy for unresectable or recurrent gastric cancer Naoki Shinno(Department of Gastroenterological Surgery, Osaka International Cancer Institute) The impact of ineligibility on treatment outcomes in elderly patients with advanced gastric cancer Takayuki Ando(University of Toyama, Deparment of Gastroenterology, Toyama city) What's the treatment for patients who are considered unfit for clinical trials? Takeshi Kawakami(Division of Gastrointestinal Oncology, Shizuoka Cancer Center) Special Remarks Yu Sakata(Misawa City Hospital) Room3~4 10:05~11:35 英語 in English Room 4 Convention Hall A-2 Workshop 4 Treatment strategy for carcinoma of the gastric remnant Chairs Eigo Otsuji( Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine) Hideaki Shimada( Department of Surgery, Graduate School of Medicine, Toho University) WS4-1 WS4-2 WS4-3 WS4-4 WS4-5 Surgical treatment of cancer in the remnant stomach Xiang Hu(Department of General Surgery, The First Affiliated Hospital Dalian Medical University, Dalian, China) Surgery for Gastric Cancer in Remnant Stomach Sung Hoon Noh(Yonsei University College of Medicine, Seoul, South Korea) Gastric tube cancer after esophagectomy; A type of the carcinoma of gastric remnant Yoshifumi Baba(Department of Gastroenterological Surgery, Kumamoto University) Prognosis of surgical cases of remnant gastric cancer with lymph nodes metastasis Kazuaki Matsui(Department of Surgery, Keio University School of Medicine) Preoperative chemotherapy for remnant gastric cancer Masaki Aizawa(Department of Surgery, Niigata Cancer Center Hospital) 69

7 WS4-6 WS4-7 The treatment strategy for remnant gastric cancer Mitsumasa Yoshida(Hiroshima City Hiroshima Citizens Hoshipital, Department of Surgery, Hiroshima, Long-term outcome and postoperative complication in remnant gastric cancer surgery Shinji Morita(National Cancer Center Hospital, Tokyo, Special Remarks Hiroyuki Konno(Hamamatsu University School of Medicine) 14:05~15:35 日本語 in Japanese Room 4 Convention Hall A-2 第 4 会場コンベンションホール A-2 Workshop 5 The role of multidisciplinary team medical treatment for gastric cancer ワークショップ5 胃がんに対する多職種チーム医療の役割 Chairs Masaichi Ohira( Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine) Akinori Takagane( Department of Surgery, Hakodate Goryoukaku Hospital) 座長 大平雅一 ( 大阪市立大学医学部附属病院消化器外科 ) 高金明典 ( 函館五稜郭病院診療部外科 ) WS5-1 WS5-2 WS5-3 WS5-4 WS5-5 WS5-6 Interprofessional collaboration to improve quality and efficiency of medical care 医療の質と効率性向上のために求められる専門職間の協働と連携 Mia Kobayashi(Welfare and Medical Intelligence, Chiba University Hospital, Chiba, 小林美亜 ( 千葉大学医学部附属病院 ) Relationship between nutritional counseling and nutritional status in patients with gastric cancer 胃癌患者における術後栄養指導と栄養状態の変化 Hiromi Matsuo(Department of Nutrition Management, NST, The Cancer Institute Hospital of JFCR, Tokyo, 松尾宏美 ( がん研有明病院栄養管理部 NST) Study on the suppression effect of body weight loss by nutritional counselling after gastrectomy 胃切除術後の栄養食事指導による体重減少抑制効果についての検討 Akihiro Kozuka(Komaki City Hospital, Department of Nutrition, Aichi, 小塚明弘 ( 小牧市民病院栄養科 ) Improvement of nutritional status after gastric cancer surgery by aggressive nutritional guidance 胃癌術後患者への積極的栄養指導による栄養状態の改善効果に関する検討 Norihito Kubo(Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine) 久保寛仁 ( 弘前大学大学院医学研究科消化器外科学講座 ) Perioperative intervention of dysphagia rehabilitation for elderly gastric cancer patients 高齢者胃切除における嚥下リハビリ介入の有用性 Atsushi Yasuda(Department of Surgery, Kindai University Faculty of Medicine, Osaka, 安田篤 ( 近畿大学医学部外科 ) Preoperative enhanced weight-loss program conducted by multidisciplinary team 多職種介入による 術前強化減量プログラム Yusuke Matsumoto(Department of Surgery, Japanese Red Cross Society Himeji Hospital, Hyogo, 松本祐介 ( 姫路赤十字病院外科 ) 70

8 WS5-7 特別発言 Preoperative weight loss program in LG 腹腔鏡下胃切除術における多職種介入術前減量プログラムの有用性 Hideya Kashihara(Department of Surgery, Tokushima University, Tokushima, 柏原秀也 ( 徳島大学消化器 移植外科 ) Toshiro Konishi(Division of Medical Nutrition Faculty of Healthcare, Tokyo Healthcare University) 小西敏郎 ( 東京医療保健大学医療栄養学科 ) 15:45~17:15 日本語 in Japanese Room 4 Convention Hall A-2 第 4 会場コンベンションホール A-2 Special Session 2 ASCO-GI reports, DDW reports スペシャルセッション2 日本胃癌学会研究推進委員会報告 Chair Yoshiyuki Fujiwara( Department of Surgery, Faculty of Medicine, Tottori University) 座長 藤原義之 ( 鳥取大学医学部病態制御外科 ) Room4 SS2-1 SS2-2 SS2-3 SS2-4 SS2-5 SS2-6 Epidemic Research of Treatment for Gastric Outlet Stenosis due to Gastric Cancer in Japan 胃癌による胃出口狭窄症に対する治療法の実態調査 Yoshio Haga(JCHO Amakusa Central General Hospital) 芳賀克夫 (JCHO 天草中央総合病院 ) Multicenter observational study of QOL after surgical palliation of gastric outlet obstruction 狭窄症を伴い経口摂取不能となった初発治癒切除不能進行胃癌に対する緩和手術 :QOL score による前向き研究 Kazumasa Fujitani(Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka, 藤谷和正 ( 大阪急性期総合医療センター ) Effects of pre or postoperative sarcopenia on prognosis in gastric cancer patients after gastrectomy 胃癌手術患者における術前 術後サルコペニアの予後に与える影響 Kazuya Kuwada(Department of Gastroenterological Surgery Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences) 桒田和也 ( 岡山大学大学院医歯薬学総合研究科消化器外科学 ) Effect of Hospital and Surgeon Volume on Postoperative Outcomes after Gastrectomy Based on NCD Data NCD データベースを用いた胃切除術後合併症に与える hospital and surgeon volume の影響 Masaaki Iwatsuki(Dept.of Gastroenterological Surgery, Kumamoto Univ.) 岩槻政晃 ( 熊本大学大学院消化器外科学 ) Surgical outcomes of laparoscopic distal and total gastrectomy compared to open gastrectomy 本邦における胃癌に対する腹腔鏡下手術成績に関する後ろ向き調査研究 Yoshihiro Kakeji(Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, 掛地吉弘 ( 神戸大学大学院医学研究科外科学講座食道胃腸外科学分野 ) Oncological efficacy of laparoscopic gastrectomy for advanced cancer (LOC-A study) 進行胃癌に対する腹腔鏡下胃切除の妥当性の検証 : 傾向スコア解析を用いた多施設共同研究 (LOC-A study) Takahiro Kinoshita(Gastric Surgery Division, National Cancer Center Hospital East, Kashiwa, 木下敬弘 ( 国立がん研究センター東病院胃外科 ) 71

9 SS2-7 International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 Stage IV 胃癌における Conversion Therapy に関する国際共同観察研究 (CONVO-GC-1) Kazuhiro Yoshida(Department of Surgical Oncology, Gifu University, Gifu, 吉田和弘 ( 岐阜大学医学部腫瘍外科 ) (Thursday) Room 5 2 月 28 日 ( 木 ) 第 5 会場 8:30~10:00 英語 in English Room 5 Convention Hall B Special Session 1 Molecular biology for diagnosis and treatment of gastric cancer Chair Toshikazu Ushijima( National Cancer Center Research Institute) SS1-1 SS1-2 SS1-3 Gastric cancer phenotypic and molecular heterogeneity implications for diagnosis, prognosis prediction and therapy Heike I Grabsch(Professor in Gastrointestinal Cancer Pathology, Maastricht University Medical Centre+, Maastricht, NL) Retrospective Validation of Predictive Biomarker for Topoisomerase I Inhibitors Ajit Bharti(Boston University Medical School, Boston, MA, USA) Is Gastric Cancer able to be targeted by Epigenetic Therapy? Malcolm Brock(Johns Hopkins University School of Medicine, Baltimore, USA) 10:05~11:35 日本語 in Japanese Room 5 Convention Hall B 第 5 会場コンベンションホール B Symposium 3 Joint symposium with the Japanese Society for Helicobacter Research シンポジウム3 合同シンポジウム ( 日本ヘリコバクター学会 ) Chairs Toshiro Sugiyama( Department of Cancer Prevention and Therapeutics,Graduate School of Medicine, University of Toyama) Takuji Gotoda( Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine) 座長 杉山敏郎 ( 富山大学附属病院消化器内科 ) 後藤田卓志 ( 日本大学医学部内科学系消化器肝臓内科学分野 ) SY3-1 SY3-2 SY3-3 SY3-4 H. pylori and gastric cancer in Japan compared to Asian and Western countries 欧米 アジア 日本の胃がんとピロリ Kazunari Murakami(Department of Gastroenterology, Oita University, 村上和成 ( 大分大学医学部消化器内科 ) Endoscopic diagnosis of gastric cancer after H. pylori eradication 除菌後胃癌の内視鏡診断 Masaaki Kobayashi(Division of Gastroenterology, Niigata Cancer Center Hospital, Niigata, 小林正明 ( 新潟県立がんセンター新潟病院内科 ) Pathological Characteristics of Helicobacter pylori Negative Gastric Cancer ヘリコバクターピロリ陰性胃癌の病理学的特徴 Yoichi Ajioka(Division of Molecular and Diagnostic Pathology, Niigata University, Graduate School of Medical and Dental Sciences, Niigata, 味岡洋一 ( 新潟大学大学院医歯学総合研究科分子 診断病理学分野 ) Strategies for eliminating death from gastric cancer in Japan, primary and secondary prevention 本邦における胃がん対策 除菌による一次予防と胃癌検診による二次予防 Katsuhiro Mabe(Dep. of Gastroenterology, National Hospital Oragnization Hakodate Hospital, Hakodate, Hokkaido, 間部克裕 ( 国立病院機構函館病院消化器科 ) 72

10 (Thursday) Room 6 2 月 28 日 ( 木 ) 第 6 会場 8:30~10:00 英語 in English Room Meeting Room Workshop 2 Establishment of QOL assessment after gastrectomy Chairs Koji Nakada( Department of Laboratory Medicine, The Jikei University Daisan Hospital) Shinichi Kinami( Kanazawa Medical University Department of Surgical Oncology) WS2-1 WS2-2 WS2-3 WS2-4 WS2-5 WS2-6 The significance of postgastrectomy QOL evaluation by using PGSAS-45 questionnaire Koji Nakada(Department of Laboratory Medicine, Daisan Hospital Jikei University School of Medicine) Evaluation by PGSAS-37 for gastric cancer patients with pylorus-preserving gastrectomy Masazumi Takahashi(Division of Gastroenterological Surgery, Yokohama Municipal Citizen's Hospital) Usefulness and problem of QOL assessment after gastrectomy by PGSAS Tomohiro Osaki(Tottori Prefectural Central Hospital) The update of the EORTC Quality of Life Gastric module QLQ-STO22 in collaboration with Asia Mitsumi Terada(Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium) Clinical significance of diet-targeted QOL assessment after gastrectomy Michitaka Honda(Fukushima Medical University) Establishment of QOL assessment after gastrectomy : Korean experience Hyuk-Joon Lee(Department of Surgery and Cancer Research Institute Seoul National University College of Medicine, Korea) Special Remarks Michio Kaminishi(Showa General Hospital) Room4~6 10:05~11:35 英語 in English Room Meeting Room Symposium 4 The new insights of molecular profiling Chairs Atsushi Ochiai( Exploratory Oncology Research and Clinical Trial Center, National Cancer Center) Wataru Yasui( Department of Molecular Pathology, Hiroshima University) SY4-1 SY4-2 SY4-3 SY4-4 (Epi)Genomic Predictors of Treatment Response in Gastric Cancer Patrick Tan(Duke-NUS Medical School Cancer Science Institute of Singapore, NUS, Singapore) Genomics of tumor microenvironment in diffuse-type gastric carcinoma Shumpei Ishikawa(Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo) MSI-low is an intermediate type between MSI-high and MSS in EGJ adenocarcinoma Yu Imamura(Dpt. Gastroenterological Surgery, Cancer Institute Hospital, Microsatellite instability of gastric cancer an example of possible personalized surgical treatment Polom Karol(General Surgery and Surgical Oncology Department, University of Siena, Siena, Italy / Surgical Oncology Department, Medical University of Gdansk, Gdansk, Poland) Special Remarks Kosei Hirakawa(Kashiwara Municipal Hospital) 73

11 14:10~16:30 英語 in English Room Meeting Room CGCA Session Neoadjuvant therapy of local advanced gastric cancer Chairs Jiafu Ji( Peking University Cancer Hospital & Institute) Masanori Terashima( Division of Gastric Surgery, Shizuoka Cancer Center) Takeshi Sano( Japanese Foundation for Cancer Research Cancer Institute Hospital, Hospital Director) Panel discussion Yasuhiro Kodera( Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine) Xinyu Qin( Fudan University Zhongshan Hospital) Zhenggang Zhu( Shanghai Jiaotong University School of Medicine, Ruijin Hospital) Huimian Xu( The First Hospital of China Medical University) Han Liang( Tianjin Medical University Cancer Hospital & Institute) Xiangdong Cheng( Zhejiang Cancer Hospital) Chang-ming Huang( Fujian Medical University Union Hospital) Guoxin Li( Nanfang Hospital, Southern Medical University) Jian Suo( The First Hospital of Jilin University) Xiang Hu( The First Affiliated Hospital of Dalian Medical University) Hui Cao( Renji Hospital, Shanghai Jiao Tong University, School of Medicine Shanghai) Zekuan Xu( The First Affiliated Hospital of Nanjing Medical University) Ziyu Li( Peking University Cancer Hospital & Institute) Xiaoming Lu( Union Hospital, Tongji Medical College, Huazhong University of Science and Technology) 14:10-14:15 Welcome Jiafu Ji(Peking University Cancer Hospital & Institute) Masanori Terashima(Division of Gastric Surgery, Shizuoka Cancer Center) Takeshi Sano(Japanese Foundation for Cancer Research Cancer Institute Hospital, Hospital Director) 14:15-14:30 Neoadjuvant Anti-Angiogenesis therapy for Gastric Cancer in China Chen Li(Shanghai Jiaotong University School of Medicine, Ruijin Hospital) 14:30-14:45 An Randomized, Multicenter, Open-label, Phase III Trial Comparing Neoadjuvant Chemoradiotherapy versus Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma (Neo-CRAG study) Wei Wang(Department of Gastric Surgery, Sun Yat-sen University Cancer Center) 14:45-15:00 Randomized, Multicenter,Controlled Evaluation of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Advanced Gastric Cancer Patients Wang Xin-xin(Department of General Surgery, the First Medical Center of Chinese PLA General Hospital, Fuxing Road 28, , Beijing, China) 15:00-15:15 A single center, prospective trial of apatinib plus oxaliplatin and capecitabine (XELOX) in the preoperative treatment of locally advanced gastric cancer with lymph node metastasis followed by D2 rescetion Wang Xuefei(Department of General Surgery, Gastric Cancer Center, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai , China) 15:15-15:30 A prospective study of apatinib plus concurrent neoadjuvant chemoradiotherapy for HER-2 negative adenocarcinoma of gastroesophageal junctional cancer in Siewert s type II, III: Short term efficacy Qun Zhao(Department of Gastrointestinal Surgery, Forth Hospital of Hebei Medical University, Hebei, China) 15:30-15:45 Neoadjuvant chemotherapy trials for gastric cancer in Japan Yasuhiro Kodera(Aichi Cancer Center Hospital, 15:45-16:15 Panel discussion All 74

12 (Thursday) Room 7 2 月 28 日 ( 木 ) 第 7 会場 8:30~9:19 英語 in English Room Meeting Room Video Presentation 1 Robotic gastrectomy 1 Chair Koichi Suda( Department of Gastroenterological Surgery, Fujita Health University, Toyoake, VE-01-1 VE-01-2 VE-01-3 VE-01-4 VE-01-5 VE-01-6 VE-01-7 Robotic gastrectomy as a solo surgery: standardized exposure and tips for using monopolar scissors Hiroshi Okabe(Department of Surgery, Otsu City Hospital) Robotic gastrectomy using an ultrasonically activated device for gastric cancer Mikito Inokuchi(Department of Gastrointestinal Surgery, School of Medicine, Tokyo Medical and Dental University, Tokyo, Robotic gastrectomy using ultrasonic shears Naoshi Kubo(Department of Gastroenterological Surgery, Osaka City General Hospital) The 3D simulation is useful for the robotic suprapancreatic LN dissection with ultrasonic scalpel Kenoki Ohuchida(Department of Surgery and Oncology, Kyushu University / Center of Advanced Medical Innovation, Kyushu University) Bleeding and energy device in robot-assisted gastrectomy Shirou Kuwabara(Niigata City General Hospital, Dep. of Surgery) Our device to decide oral side cutting line of the stomach in robotic distal gastrectomy Takeshi Kubota(Department of Digestive Surgery, Kyoto Prefectural University of Medicine) Pancreas-protective D2 lymphadenectomy in robot-assisted gastrectomy En Amada(Department of Surgery, Keio University School of Medicine) Room6~7 9:19~10:08 英語 in English Room Meeting Room Video Presentation 2 Robotic gastrectomy 2 Chair Takeshi Omori( Department of Gastroenterological Surgery, Osaka International Cancer Institute) VE-02-1 VE-02-2 VE-02-3 VE-02-4 VE-02-5 VE-02-6 Tips for standardization of robot-assisted gastric cancer surgery and its clinical results Noriyuki Inaki(Juntendo University Urayasu Hospital, Urayuasu, The surgical procedure and short-term outcome of robotic gastrectomy in the introduction period Kazunari Misawa(Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, The usefulness of our step-wise training system for robotic assisted gastrectomy Kozo Yoshikawa(Division of Digestive Surgery, Department of Surgery, School of Medicine, Tokushima University, Tokushima, Induction experience of EndoWrist stapler for robotically assisted distal gastrectomy Yusuke Ozaki(Hamamatsu University School of Medicine, Department of Surgery) Robotic complete lymphadenectomy at the splenic hilum during total gastrectomy Toshiyasu Ojima(Second Department of Surgery, Wakayama Medical University, Wakayama, The experience of robot assisted total gastrectomy with splenectomy for advanced gastric cancer Yutaka Tamamori(Department of Gastroenterological Surgery, Osaka City General Hospital, Osaka, 75

13 VE-02-7 Robotic proximal gastrectomy with hinged double flap method Kazuaki Tanabe(Department of Gastroenterological and Transplant Surgery, HIroshima University, Hiroshima, 10:08~10:50 英語 in English Room Meeting Room Video Presentation 3 Reconstruction after laparoscopic total gastrectomy 1 Chair Noriyuki Inaki( Juntendo University Urayasu Hospital, Urayasu, VE-03-1 VE-03-2 VE-03-3 VE-03-4 VE-03-5 VE-03-6 Esophagojejunostomy after laparoscopic total gastrectomy by overlap method using linear stapler Ken Yuu(Department of Surgery, BellLand General Hospital) Our procedure with overlap method in the reconstruction of laparoscopic total gastrectomy Jun Isogaki(Fujinomiya City General Hospital) The knock of esophagojejunostomy in laparoscopy-assisted total gastrectomy Takanobu Yamada(Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Early surgical outcomes of intracorporeal esophagojejunostomy with overlap method Yuri Tanaka(National Cancer Center Hospital East) Short-term results of laparoscopic esophagojejunostomy after total gastrectomy Toshinaga Nabae(Department of Surgery, JCHO Kyushu Hospital) Esophagojejunostomy with Linear Stapler in Total Gastrectomy is Safe Toshiyuki Tanahashi(Department of Surgical Oncology, Gifu University, Gifu, 10:50~11:25 英語 in English Room Meeting Room Video Presentation 4 Reconstruction after laparoscopic total gastrectomy 2 Chair Keizo Taniguchi( Teikyo University Hospital Mizonokuchi) VE-04-1 VE-04-2 VE-04-3 VE-04-4 VE-04-5 Trouble shooting for esophagusjujunostomy in laparoscopic total gastrectomy Koichi Murata(Dept. of Surgery, Kita-Harima Medical Center) The crossover technique for intracorporeal esophagojejunostomy after laparoscopic total gastrectomy SangWoong Lee(Dept. of General and Gastroenterological Surgery, Osaka Medical College, A new laparoscopic esophagojejunostomy procedure "China Stitch" inspired by vascular anastomosis Zhipeng Sun(Oncology Surgery Department, Beijing Shijitan Hospital, Capital Medical University, China (Peking University Ninth School of Clinical Medicine)) A new option for intracorporeal circular-stapled esophagojejunostomy : Use of a peroral endoscope Yoshikazu Hashimoto(Department of Surgery, School of Medicine, Tokyo, Comparision of overlap method and functional method for totally laparoscopic total gastrectomy Hee Sung Kim(Department of Gastric Surgery, University of Ulsan College of Medicine, Asan Medical Center) 76

14 14:05~14:54 英語 in English Room Meeting Room Video Presentation 5 Laparoscopic proximal gastrectomy Chair Masahiko Nishizaki( Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, VE-05-1 VE-05-2 VE-05-3 VE-05-4 VE-05-5 VE-05-6 VE-05-7 Reconstruction time of laparoscopic proximal gastrectomy with double-flap technique Takuma Ohashi(Department of Gastroenterological Surgery, Cancer Institute Hospital) Technical notes and outcomes of the double-flap technique following proximal gastrectomy Tetsuya Kagawa(Department of Gastroenterological Surgery, National Hospital Organization, Shikoku Cancer Center) Double flap with No-knife stapler reconstruction for esophagogastric junction cancer Kazunori Shibao(Dept. of Surgery I, Univ. of Occup & Environl Health, Treatment outcomes of esophagogastric anastomosis with hand-sewn technique after LPG Toshiyuki Kosuga(Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine) Application of double tract gastric interposition after radical proximal gastrectomy Chao Yue(Department of General Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China) Tips for double tract reconstruction after laparoscopic proximal gastrectomy for gastric cancer Haruhiko Cho(Department of Surgery, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital) Proximal vs total gastrectomy for advanced gastric cancer in the upper third of the stomach Gang Li(Department of General Surgery, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China) Room7 14:54~15:36 英語 in English Room Meeting Room Oral Presentation 01 Molecular biology 1 Chair Sachiyo Nomura( Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, OE-01-1 OE-01-2 OE-01-3 Identification of DNA adducts as a history of mutagenic exposure in gastric cancer patients Yuji Iwashita(Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Identification of the mechanism underlying gastric cancer invasive growth depending on tumor stroma Takatsugu Ishimoto(Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan / International Research Center of Medical Sciences, Kumamoto University, Kumamoto, The glycosylating enzyme GALNT2 suppresses gastric cancer progression by reducing EGFR activities Yi-Ting Lin(Department of Anatomy and Cell Biology, Medcial School, National Taiwan University) 77

15 OE-01-4 OE-01-5 OE-01-6 Distinctive genetic aberrations in solid type poorly differentiated adenocarcinoma of stomach Hiroshi Ichikawa(Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, CpG island methylator phenotype is induced by SWI/SNF defects in gastric cancers Harumi Yamada(Division of Epigenomics, National Cancer Center Research Institute, Tokyo, The autophagy of gastric cancer stem cells Shingo Togano(Dept. of Gastrointestinal Surg, Graduate School, Osaka City Univ) 15:36~16:18 英語 in English Room Meeting Room Oral Presentation 02 Molecuar biology 2 Chair Takeshi Kuwata( Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, OE-02-1 OE-02-2 OE-02-3 OE-02-4 OE-02-5 OE-02-6 High expression of RNF126 is associated with poor prognosis of gastric cancer Kazuhiro Migita(Department of Surgery, Nara Medical University) DNA copy-number profile of gland-forming gastric carcinomas Tu Thanh Duong(Department of Pathology, Division of Molecular and Diagnostic Pathology, Shiga University of Medical Science, Shiga, Japan / Department of Pathology, University of Medicine and Pharmacy at Ho Chi Minh City) TP53 inactivation mechanisms in GAED Noboru Yatagai(Department of Gastroenterology, Juntendo University, School of Medicine, Tokyo, The role and biology of tumor-associated stroma progressing in scirrhous gastric cancer Suguru Kasai(Department of Medical Oncology, Kanazawa Medical University, Ishikawa, FRAS1 is involved in the tumorigenesis of liver metastasis from gastric cancer Shinichi Umeda(Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Aichi, Exosomes derived from cancer associated fibroblasts enhance drug resistance of gastric cancer cells Tomoyuki Uchihara(Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 16:18~16:46 英語 in English Room Meeting Room Oral Presentation 03 Translational research 2 Chair Takatsugu Ishimoto( Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, OE-03-1 OE-03-2 OE-03-3 OE-03-4 演題取り下げ 演題取り下げ Protein subtyping of diffuse-type gastric cancer using formalin-fixed paraffinembedded samples Wenwen Huang(Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China / State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences, Beijing, China) 演題取り下げ 78

16 OE-03-5 OE-03-6 Tissueoid cell culture system using the silicate fiber scaffold Cellbed Ken-ichi Mukaisho(Division of Molecular Diagnostic Pathology, Department of Pathology, Shiga University of Medical Science, Shiga, Patient-Derived Tumor Xenograft Model of Gastric Cancer is Predictive Factor in Disease Recurrence Yong Liu(Department of Gastroenterological Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China) (Thursday) Room 8 2 月 28 日 ( 木 ) 第 8 会場 8:30~9:12 英語 in English Room Meeting Room Oral Presentation 04 H. pylori Chair Hiroyasu Iishi( Itami City Hospital, Department of Gastroenterology) Room7~8 OE-04-1 OE-04-2 OE-04-3 OE-04-4 OE-04-5 OE-04-6 Potential of Helicobacter pylori-negative signet ring cell carcinoma to invade the submucosal layer Naoki Yorita(Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Safety of H.pylori eradication therapy with a potassium-competitive acid blocker in children Chika Kusano(Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Pitfall of early gastric cancer after H.pylori eradication Toshiyuki Wakatsuki(Department of Gastroenterology & Hepatology, Okayama Medical Center, Okayama, Influence of gastric surgery for gastric cancer on the Streptococcus in gut microbiota Chikara Iino(Department of Gastroenterology, Hirosaki University Graduate School of Medicine) Clinical correlation between serum pepsinogen level and gastric atrophy in the gastric neoplasm Jae Hwang Cha(Medicine, Dong-A University Medical Center) 演題取り下げ 9:12~9:47 英語 in English Room Meeting Room Oral Presentation 05 EGC/ ESD Chair Kenshi Yao( Department of Endoscopy, Fukuoka University Chikushi Hospital) OE-05-1 OE-05-2 OE-05-3 OE-05-4 The influence of the number of biopsy samples on lymph node metastasis in early gastric cancer Noriko Wada(Department of Gastroenterological Surgery, Ikeda City Hospital, Osaka, Risk Stratification for Lymph Node Metastasis in Patients with Early Gastric Cancer Yusuke Takashima(Department of Surgery, Division of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, Additional surgery after non-curative resection of ESD for early gastric cancer Shiro Iwagami(Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Development of esophageal cancer after ESD for early gastric cancer Waku Hatta(Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, 79

17 OE-05-5 Correlation Between Healing Type of Lesion and Recurrence in Gastric Neoplastic Lesions Jin Seok Jang(Dong-A University College of Medicine, Busan, Korea) 9:47~10:22 英語 in English Room Meeting Room Oral Presentation 06 ESD Chair Yusuke Horiuchi( Department of Endoscopy, Cancer Institute Hospital Ariake, Tokyo, OE-06-1 OE-06-2 OE-06-3 OE-06-4 OE-06-5 Lesion range diagnosis method of undifferentiated early gastric cancer using magnifying endoscopy Rieko Nakamura(Department of Surgery, School of Medicine, Keio University) Indication of ESD for early gastric cancer with mixed-type histology diagnosed by biopsy Kazuya Hosotani(Division of Endoscopy, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Comparison of curability based on section intervals of endoscopic submucosal dissection specimens Noboru Kawata(Division of Endoscopy, Shizuoka Cancer Center) The ecura system is useful deciding additional surgery after non-curative ESD in elderly Atsuko Ohki(Department of Surgery, School of Medicine, Kyorin University, Tokyo, Polysomnography can detect respiratory disturbance during sedation for gastric ESD in detail Masaya Uesato(Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, 10:22~10:57 英語 in English Room Meeting Room Oral Presentation 07 Biomarker 1 Chair Sachio Fushida( Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, OE-07-1 OE-07-2 OE-07-3 OE-07-4 OE-07-5 Malignant potential of long non-coding RNA RPPH1 in gastric cancer Shinpei Ogino(Division of Digestive Surgery, Kyoto Prefectural University of Medicine) Evaluation of circulating cell free- repeated DNA sequences as a biomarker for gastric cancer Kazuhide Ko(Department of Gastrointestinal Surgery, Nippon Medical School) Clinicopathological significance of fibroblast growth factor receptor 2 in gastric cancer Kenji Kuroda(Department of Gastroenterology, Osaka City University, Osaka, Japan / Oncology Institute of Geriatrics and Medical Science, Osaka City University Graduate School of Medicine, Osaka, FGFRs were adverse prognostic factors and biomarkers for FGFR inhibition response in gastric cancer Yuan Li(Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China) The role of CD 44 variant 9 and Ki 67 as a prognostic factor in early gastric cancer Won Sup Lee(Department of Internal Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Republic of Korea) 80

18 10:57~11:25 英語 in English Room Meeting Room Oral Presentation 08 Biomarker 2 Chair Etsuro Bando( Shizuoka Cancer Center, Division of Gastric Surgery) OE-08-1 OE-08-2 OE-08-3 OE-08-4 Dynamic changes of genomic instability on ctdna reflect therapeutic response in gastric cancer Zuhua Chen(Peking University Cancer Hospital & Institute, Beijing, China) Clinical utility of Trastuzumab for the CTC-HER2 positive advanced gastric cancer patients Daisuke Matsushita(Dept. of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University) GLUT3 promotes Herceptin resistance in HER2+ GC by accelerating glycolytic induced vascular abnormal Jiaolong Shi(Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China) The effect of metformin on prognosis in advanced gastric cancer associated with type 2 DM Ho Seok Seo(Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea) Room8 14:05~14:40 英語 in English Room Meeting Room Oral Presentation 09 Translational research 1 Chair Mitsuro Kanda( Department of Gastroenterological Surgery, Nagoya University) OE-09-1 OE-09-2 OE-09-3 OE-09-4 OE-09-5 Treatment for CY suspicious gastric cancer patients who have no other distant metastases Yumiko Yamashita(Division of Digestive and General Surgery, Niigata University) Detection of free cancer cells after gastric cancer surgery by plural cancer specific gene marker Katsushi Takebayashi(Department of Surgery, Shiga University of Medical Science) Investigation of specific expression of micrornas in Alpha-fetoprotein(AFP) -producing gastric cancer Suguru Maruyama(First Department of Surgery, Faculty of Medicine University of Yamanashi) Volatile Organic Compounds as a Biomarker in Gastric Adenocarcinoma Through Exhaled Breath Analysis Yoon Ju Jung(Division of Gastrointestinal Surgery, Department of General Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea) 演題取り下げ 14:40~15:22 英語 in English Room Meeting Room Oral Presentation 10 EGJ 1 Chair Takushi Yasuda( Division of Esophago-Gastric Surgery, Department of Surgery, Kindai University Faculity of Medicine) OE-10-1 Reconstruction using Gastric Conduit in Proximal Gastrectomy for Esophago-Gastric Junction Tumor Eiichiro Nakao(Department of Surgery, Osaka Red Cross Hospital) 81

19 OE-10-2 OE-10-3 OE-10-4 OE-10-5 OE-10-6 Transmediastinal radical esophagectomy for EGJ cancer Atsushi Shiozaki(Div. of Digestive Surg., Dept. of Surg., Kyoto Prefectural Univ. of Med., Kyoto, Minimally invasive abdominal and left thoracic approach (MALTA)for Siewert type II adenocarcinoma Yuma Ebihara(Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine Sapporo, Rt.transthoracosopic approach for lymphadenectomy of lower mediastinum and anastomosis in EGJ cancer Hiroshi Makino(Department of Surgery, Nippon Medical School, Tama Nagayama Hospital) Surgical Strategies and Disease Characteristics of EJ-Junction Tumors in Korea and Germany Felix Berlth(Department of Surgery, Seoul National University Hospital, Korea / Department of General, Visceral and Cancer Surgery, University Hospital of Cologne, Germany) Valvuloplastic esophagogastrostomy using DFT for EGJC after proximal gastrectomy Masahiko Nishizaki(Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 15:22~15:57 英語 in English Room Meeting Room Oral Presentation 11 EGJ 2 Chair Daisuke Ichikawa( First Department of Surgery, University of Yamanashi) OE-11-1 OE-11-2 OE-11-3 OE-11-4 OE-11-5 Multidisciplinary approach for resectable advanced esophagogastric junction carcinoma Mikihito Nakamori(Second Department of Surgery, Wakayama Medical University, Wakayama, The feasibility of ESD and the risk of lymph node metastasis in esophagogastric junctional carcinoma Ryosuke Ikeda(Division of Endoscopy, Yokohama City University Medical Center, Yokohama, Impact of lymphatic invasion in esophageal region on mediastinal LN metastasis in patients with AEG Shizuki Sugita(Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, The optimal surgical approach to esophagogastric junction cancer Shuhei Mayanagi(Department of Surgery, School of Medicine, Keio University, Tokyo, Examination of the treatment outcome of the esophago-gastric junctional cancer Yoshiro Imai(Department of General and Gastroenterological Surgery, Osaka Medical College) 15:57~16:39 英語 in English Room Meeting Room Oral Presentation 12 Laparoscopic gastrectomy for advanced gastric cancer Chair Yasushi Rino( Department of Surgery, Yokohama City University) OE-12-1 Feasibility of laparoscopic gastrectomy with total omentectomy for advanced gastric cancer Akio Kaito(Gastric Surgery Division, National Cancer Center Hospital East, Kashiwa, 82

20 OE-12-2 OE-12-3 OE-12-4 OE-12-5 OE-12-6 Feasibility of laparoscopic total gastrectomy with splenectomy for upper third gastric cancer Eigo Akimoto(Department of Gastric Surgery, National Cancer Center Hospital East, Chiba, Outcomes of laparoscopic distal gastrectomy for advanced gastric cancer Michihisa Iida(Dept. of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi Univ) Long-term outcome of laparoscopic versus open total gastrectomy for advanced gastric cancer Hayemin Lee(The Catholic Uinversity of Korea) Laparoscopic versus open total gastrectomy for advanced gastric cancer: a retrospective study Zekuan Xu(Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China) Laparoscopic gastrectomy in advanced gastric cancer Sa-Hong Min(Seoul National University Bundang Hospital) Room8~9 16:39~17:07 英語 in English Room Meeting Room Oral Presentation 13 Laparoscopic total and proximal gastrectomy Chair Mikito Inokuchi( Department of Gastrointestinal Surgery, School of Medicine, Tokyo Medical and Dental University, Tokyo, OE-13-1 OE-13-2 OE-13-3 OE-13-4 Short-term outcome of laparoscopic total gastrectomy in NCD prospective cohort study Tsuyoshi Etoh(Department of Gastroenterological and Pediatric Surgery, Oita University, Oita, Short-term Outcomes of Open versus Laparoscopic Total Gastrectomy for Gastric cancer Yoona Chung(Department of Surgery, Kyung Hee University Hospital at Gangdong) Surgical outcomes of laparoscopic gastrectomy for gastric cancer in the upper stomach: LPG vs.lstg Koichi Sato(Department of Gastroenterological Surgery, Ehime Prefectural Central Hospital) Incidence of gallstones after laparoscopic proximal gastrostomy (LPG) Atsuyuki Maeda(Department of Surgery, Ogaki Municipal Hospital) (Thursday) Room 9 2 月 28 日 ( 木 ) 第 9 会場 8:30~9:05 英語 in English Room Meeting Room Oral Presentation 14 GIST Chair Toshiaki Hirasawa( Department of Gastroenterology, Cancer Institute Hospital Ariake, Tokyo, OE-14-1 OE-14-2 Feasibility of neoadjuvant imatinib therapy for locally advanced gastrointestinal stromal tumors Hirotoshi Kikuchi(Department of Surgery, Hamamatsu University School of Medicine) Treatment outcomes of LECS for gastric submucosal tumors Masato Mitsuda(Division of Digestive Surgery, Department of Surgery Kyoto Prefectural University of Medicine) 83